As experts debate the slow response to the Ebola outbreak in West Africa and call for better international coordination, a new analysis estimates that $22 billion was spent on global health aid in 2013, yet only a fifth of this went toward such global imperatives as research on diseases that disproportionally affect the poor, outbreak preparedness and global health leadership.

In January, 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease.